Literature DB >> 22956445

Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.

Jennifer E Potter1, Kendra A Moore.   

Abstract

Lichen sclerosus is a commonly misdiagnosed disease that is characterized by thinned, hypopigmented, crinkled skin that often forms a figure-eight shape around the vaginal and anal openings. We present a case of advanced lichen sclerosus in a 53-year-old female patient prescribed a nonsteroidal aromatase inhibitor after the excision of a breast cancer tumor. We present a diagnostic approach to lichen sclerosus by recognizing its common figure-eight pattern, and we review the known causes and treatment of lichen sclerosus. Research has shown that lichen sclerosus is more common in low estrogen states, and thus it is logical that aromatase inhibitors could increase a patient's risk for developing this disease. We therefore propose that all patients prescribed aromatase inhibitors undergo regular vulvo-vaginal exams to rule out lichen sclerosus and other hypoestrogen-related vulvo-vaginal problems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956445      PMCID: PMC3599029          DOI: 10.1007/s11606-012-2209-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  A population-based case-control study of aetiological factors associated with vulval lichen sclerosus.

Authors:  C A Higgins; M E Cruickshank
Journal:  J Obstet Gynaecol       Date:  2012-04       Impact factor: 1.246

2.  Intralesional injection of triamcinolone in the treatment of lichen sclerosus.

Authors:  F Mazdisnian; F Degregorio; F Mazdisnian; A Palmieri
Journal:  J Reprod Med       Date:  1999-04       Impact factor: 0.142

3.  Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.

Authors:  David Cella; Lesley Fallowfield; Peter Barker; Jack Cuzick; Gershon Locker; Anthony Howell
Journal:  Breast Cancer Res Treat       Date:  2006-06-21       Impact factor: 4.872

4.  ACOG Practice Bulletin No. 93: diagnosis and management of vulvar skin disorders.

Authors: 
Journal:  Obstet Gynecol       Date:  2008-05       Impact factor: 7.661

Review 5.  Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.

Authors:  Carolyn Crandall
Journal:  J Womens Health (Larchmt)       Date:  2002-12       Impact factor: 2.681

Review 6.  Local oestrogen for vaginal atrophy in postmenopausal women.

Authors:  J Suckling; A Lethaby; R Kennedy
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

7.  Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.

Authors:  A Kendall; M Dowsett; E Folkerd; I Smith
Journal:  Ann Oncol       Date:  2006-01-27       Impact factor: 32.976

Review 8.  Vulvar lichen sclerosus : pathophysiology and treatment.

Authors:  Yolanda R Smith; Hope K Haefner
Journal:  Am J Clin Dermatol       Date:  2004       Impact factor: 7.403

9.  A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.

Authors:  J E Dew; B G Wren; J A Eden
Journal:  Climacteric       Date:  2003-03       Impact factor: 3.005

10.  Successful treatment of anogenital lichen sclerosus with topical tacrolimus.

Authors:  Markus Böhm; Uta Frieling; Thomas A Luger; Gisela Bonsmann
Journal:  Arch Dermatol       Date:  2003-07
View more
  2 in total

1.  Lichen sclerosus in breast cancer survivor.

Authors:  Pedro Vieira-Baptista
Journal:  J Gen Intern Med       Date:  2013-03       Impact factor: 5.128

Review 2.  Art of prevention: The importance of dermatologic care when using aromatase inhibitors.

Authors:  Sara Behbahani; Amaris Geisler; Avani Kolla; Margaret Rush Dreker; Genevieve Kaunitz; Miriam K Pomeranz
Journal:  Int J Womens Dermatol       Date:  2021-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.